Tag Archives: Stock

Facing antitrust bull’s-eye, Google stock still at record highs because ad sales are sizzling

Facing antitrust bull’s-eye, Google stock still at record highs because ad sales are sizzling

Alphabet Inc. is the most vulnerable Big Tech company on the regulatory front, but don’t expect that to matter when the search giant reports second-quarter financial results Tuesday. The leading digital advertising company and Google GOOGL, +3.58% GOOG, +3.37% parent company faces at least five government antitrust lawsuits, primarily for its dominance in the search market. And that dominance, to no one’s surprise,… Source link

Read More »

Google’s Stock To See Little Movement Due To Mixed Results

Google’s Stock To See Little Movement Due To Mixed Results

A man walks past the logo of the US multinational technology company Google during the VivaTech … [+] trade fair ( Viva Technology), on May 24, 2018 in Paris. (Photo by ALAIN JOCARD / AFP) (Photo credit should read ALAIN JOCARD/AFP via Getty Images) AFP via Getty Images Alphabet (Google) (NASDAQ: GOOG) is scheduled to report its fiscal Q2 2021 results on Tuesday, July 27. We expect GOOG to beat the consensus estimates for revenues but miss for earnings. The company has reported… Source link

Read More »

Boston Beer stock is crashing because the hard seltzer boom is basically over

Boston Beer stock is crashing because the hard seltzer boom is basically over

Bottom line: The hard seltzer boom is over. Shares of Boston Beer crashed 20% in pre-market trading on Friday as the maker of Truly hard seltzer and Sam Adams badly whiffed on its earnings expectations and slashed full-year guidance. The culprit: Execs overestimated the potential of the hard seltzer market, which continues to slow amid rising competition and people returning to bars coming out of the COVID-19 pandemic as Yahoo Finance has reported.  “We overestimated the growth of the hard… Source link

Read More »

Stock market is at risk of a correction if this happens amid the spread of the Delta variant

Stock market is at risk of a correction if this happens amid the spread of the Delta variant

Most Wall Street strategists agree that Monday’s market rout — fueled by yawning worries about the fast-spreading COVID-19 Delta variant — should serve as a wake-up call to investors who have sent stock prices to record valuations.  And they also generally agree on what could send stocks spiraling even lower from here — a subpar second quarter earnings season chock-full of concerning guidance due to the ongoing uncertainty of the pandemic.   “This market is vulnerable to a bigger… Source link

Read More »

Moderna stock ‘has taken on a life of its own’ ahead of S&P 500 entrance

Moderna stock ‘has taken on a life of its own’ ahead of S&P 500 entrance

Moderna (MRNA) is set to join the S&P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc. (ALXN). The stock has soared amid the pandemic after its vaccine became instrumental in the fight against coronavirus. Moderna stock has “taken on a life of its own,” Michael Yee, Managing Director and Senior Research Analyst at Jefferies, told Yahoo Finance (video above). “It’s priced in a huge amount of assumptions over the next ten years that haven’t played out yet. People believe… Source link

Read More »

Delta variant will likely create a ‘sloppy’ stock market this summer: strategist

Delta variant will likely create a ‘sloppy’ stock market this summer: strategist

A likely summer of concerning COVID-19 Delta variant headlines sets the stage for an ugly stock market in the near-term, said Keith Lerner, Truist Advisory Services’ chief markets strategist.  “Our view is we’re seeing another corrective period within a bull market trend,” Lerner said in a note to clients after Monday’s brutal start to trading. “While the Delta variant complicates the near-term picture, and is likely to lead to a continuation of sloppy trading through the seasonally-weak… Source link

Read More »

Monday’s most interesting market trend amid the stock sell-off: Morning Brief

Monday’s most interesting market trend amid the stock sell-off: Morning Brief

This article first appeared in the Morning Brief. Get the Morning Brief sent directly to your inbox every Monday to Friday by 6:30 a.m. ET. Subscribe Tuesday, July 20, 2021 The stay-at-home trades comes back to life Stocks did not have a good start to the week.  On Monday all three major averages fell more than 1%, with the blue chip Dow Jones Industrial Average (^DJI) losing more than 2%. And while these declines mean the S&P 500 (^GSPC) is only 2.5% from its record, underneath the surface of… Source link

Read More »

China Signals End to $2 Trillion U.S. Stock Listing Juggernaut

China Signals End to  Trillion U.S. Stock Listing Juggernaut

(Bloomberg) — For two decades Chinese tech firms have flocked to the U.S. stock market, drawn by a friendly regulatory environment and a vast pool of capital eager to invest in one of the world’s fastest-growing economies. Now, the juggernaut behind hundreds of companies worth $2 trillion appears stopped in its tracks. Beijing’s July 10 announcement that almost all businesses trying to go public in another country will require approval from a newly empowered cybersecurity regulator… Source link

Read More »

A Deep Research on Yandex N.V. (YNDX) Stock – BOV News

A Deep Research on Yandex N.V. (YNDX) Stock – BOV News

New Street raised the price target for the Yandex N.V. (NASDAQ:YNDX) stock to “a Buy”. The rating was released on April 06, 2021. The stock was upgraded by BofA Securities, who disclosed in a research note on November 24, 2020, from Neutral to Buy and set the price objective to $80. 5 Stocks Under $10 That Are Poised to Take Off Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report… Source link

Read More »

Moderna is the Tesla of biotechs, stock price could hit $325: analyst

Moderna is the Tesla of biotechs, stock price could hit 5: analyst

Moderna, which has seen its stock surge 250% over the past year as it helps vaccinate the world from the coronavirus, will officially enter the S&P 500 on July 21. The news sent shares popping more than 8% to $282 in Friday’s session as the stock will likely be purchased by fund managers who benchmark to the S&P 500. But Jefferies analyst Michael Yee tells Yahoo Finance Live he thinks the run in Moderna stock (MRNA) is far from done.  “Moderna is the Tesla of biotech,” says Yee, pointing to… Source link

Read More »